Avidity Biosciences

RNA Micro Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$13.44

-0.22% heute

52W: $11.95 – $16.77

52W Low: $11.95 Position: 30.9% 52W High: $16.77

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

—

Erwartetes KGV

P/S Ratio

11.2x

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$208.5M

Marktkapitalisierung

Umsatzwachstum

-71.1%

YoY Umsatzwachstum

Gewinnmarge

-265.88%

Nettomarge

ROE

—

Eigenkapitalrendite

Beta

—

Marktsensitivität

Short Interest

—

% der Aktien leerverkauft

Ø Volumen

1,237,004

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

None

1 Analysten

Ø Kursziel

$25.00

+86.01% Upside

Kursziel Spanne

$25.00 – $25.00

Über das Unternehmen

Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.

Sektor: Healthcare Branche: Biotechnology Land: United States Börse: NMS

Trading-Daten

50-Day MA: $14.00

200-Day MA: $14.00

Volumen: 278,211

Ø Volumen: 1,237,004

Short Ratio: 0.05

Kurs/Buchwert: —

Verschuldung/EK: —

Free Cash Flow: $-11,653,375

Wo kann ich Avidity Biosciences kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →